Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

Thursday’s trading has closed, but AMAG is being traded in the after-hours session. After-Hours quote »
65.99
Delayed Data
As of 3:59pm ET
 +2.73 / +4.32%
Today’s Change
21.77
Today|||52-Week Range
77.73
+54.83%
Year-to-Date

Today’s Trading

Previous close63.26
Today’s open64.27
Day’s range64.21 - 67.15
Volume849,887
Average volume (3 months)723,528
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-3.27%
Earnings growth (next 5 years)+320.30%
Revenue growth (last year)+53.83%
P/E ratio12.0
Price/Sales8.64
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp-0.49-0.93%
GHDXGenomic Health Inc+0.78+3.01%
VIVOMeridian Bioscience ...+0.47+2.58%
TECHBio-Techne Corp+1.00+1.05%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$1.23
Annual revenue (last year)$124.4M
Annual profit (last year)$135.8M
Net profit margin109.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President, COO, CFO &
CAO
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers